Q linea AB
STO:QLINEA
Relative Value
The Relative Value of one
QLINEA
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 23.8 SEK,
Q linea AB
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
QLINEA Competitors Multiples
Q linea AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Q linea AB
STO:QLINEA
|
451m SEK | 53.7 | -2.4 | -2.5 | -2.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.6B USD | 4.3 | 29.1 | 16.5 | 22.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171B USD | 17 | 59.8 | 45.5 | 55.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.8B USD | 5.5 | 42.9 | 21.7 | 26.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
132.5B USD | 3.8 | 27.8 | 15.6 | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
115.7B USD | 6 | 41.5 | 24.6 | 33.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.8B USD | 2.7 | 35.1 | 12.8 | 21.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR | 2 | 21.5 | 12.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.8B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.7 | 33.2 | 23.6 | 25.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39B USD | 7.2 | 26.2 | 18.5 | 20.6 |